Top Articles

Turnitin.com is undeniably an effective deterrent to plagiarism, but it is the very issue of copyright infringement that has people questioning the legality of the site. What m

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

any people don't understand is that works do not need to be registered to be copyrighted. Every literary work that is saved to a tangible medium (this includes paper, computer

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

isk, etc.) is protected by federal copyright laws. Thus, the works submitted to Turnitin.com are copyrighted and the authors hold complete rights to the works.

What the Turnit

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

n.com system does, however, is it stores the submitted paper on their servers. This is done without the student's permission. Turnitin.com is operating under the pretense that

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

eachers will force their students to submit to Turnitin.com. Thus, student papers are stored in iParadigm's (the company that runs Turnitin.com) database. This in itself is a b

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

atant violation of the 1976 Federal Copyright Act. Turnitin.com is duplicating copyrighted material without the consent of the student. The student is forced to submit to the s

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

te, so submissions are not considered voluntary. In addition, the site does not ask for permission to store the paper, instead, it is done automatically.

iParadigm and their t

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

am of lawyers admit in their legal page that the archiving of papers is treading on shaky legal ground. They affirm, however, that their services constitute "fair use" by groun

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

s that their service does not limit the marketability of the paper. The claim that their service doesn't limit the marketability of a paper is false. If one were to sell a term

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

paper that was already in the Turnitin.com database, the paper would be of little use to a potential student buyer because any similarities from the student's paper would be re

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

flagged. The very addition of a paper to the Turnitin.com database severely limits the feasible marketability of the paper. That is, the archiving of one's paper eliminates ot

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

her students with the same assignment as potential buyers of the paper.

Another strikingly illegal aspect of the Turnitin.com service is the fact that many teachers submit stu

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ent works without the student's permission. Turnitin.com is operating under the pretense that this is occurring. When a student gives a teacher a paper for grading the assumpti

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

n is that evaluative rights are given to the teacher. In no way is the teacher entitled to submit the paper to be copied to the iParadigm servers. iParadigm is breaking copyrig

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

t laws by duplicating a paper without the copyright holder's consent.

In effect, the paper (but not the copyright) becomes property of Turnitin.com. Turnitin.com is clearly ma

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ing a profit off the papers that students submit. Without the database of some 60,000 student-submitted papers, the Turnitin.com service would not be as effective. Every paper

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ubmitted makes the service more effective and the company therefore yields greater profits. Schools that use the service have to pay large amounts of money in the thousands to

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

en thousands of dollars range. It is clear that the company is profiting off of students' copyrighted hard-work. Interestingly enough, the very place that the Turnitin.com serv

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ce originally started now has grave doubts over the legality of the Turnitin.com service.

Turnitin.com founder John Barrie was a graduate student at UC Berkeley when he starte

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

developing the software that the site runs on. Currently, UC Berkeley does not subscribe to Turnitin.com because they feel the site may be infringing upon student's copyrights

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/129306/toparticles-Turnitincom-Infringes-Upon-Students-Rights.html">Turnitin.com Infringes Upon Student's Rights</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/129306/toparticles-Turnitincom-Infringes-Upon-Students-Rights.html]Turnitin.com Infringes Upon Student's Rights[/url]

Let's face it -- none of us like to be ignored. But sending an e-mail to a colleague that commits even ONE of these four cardinal sins can mean the difference between a speedy reply ... and that big e-mail receptacle bin in the sky. :-/ Following are four common reasons why YOUR mail could be going he way of the spam, and how to reverse them to get your messages answered -- and answered *fast*.

As bad as the financial sector has been over the past few months, there are still many industries which have high capabilities of producing strong growth. The asset management industry is one of these groups. With a low P/E ratio of 21 and revenue growth apparent in almost all the upper cap companies, investing in any of these stocks will more than likely reap some benefits. The question, however, is which one will reap the most benefits? Will it be the large caps of Franklin Resources, Brookfield Asset Management, or Principal Financial Group Inc? It is quite possible. However, after looking through the strategic and fundamental elements of various companies in this industry, I see a mid-cap stock, Nuveen Investments (JNC), to have to highest potential of producing capital gains.

Tags

Links

Top Articles - Turnitin.com Infringes Upon Student's Rights

Related Articles: